Heat shock factor 1 (HSF1-pSer326) predicts response to bortezomib-containing chemotherapy in pediatric AML: a COG report.
Hoff FW, van Dijk AD, Qiu Y, Ruvolo PP, Gerbing RB, Leonti AR, Jenkins GN, Gamis AS, Aplenc R, Kolb EA, Alonzo TA, Meshinchi S, de Bont ESJM, Bruggeman SWM, Kornblau SM, Horton TM.
Hoff FW, et al. Among authors: qiu y.
Blood. 2021 Feb 25;137(8):1050-1060. doi: 10.1182/blood.2020005208.
Blood. 2021.
PMID: 32959058
Free PMC article.
Clinical Trial.